Search Results

Filter
  • 1-10 of  912 results for ""Dermatitis, Atopic""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network meta-analysis.

  • Authors : Xiong M; Department of Dermatology, the Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China.; Gao Q

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/complications ; Pruritus*/Pruritus*/Pruritus*/drug therapy

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2432930. Date of Electronic Publication: 2024 Nov 26.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study.

  • Authors : Darbellay B; Institut central des hopitaux valaisans (ICHV), Sion, Switzerland.; Dermatology Private Practice, Orsières and Martigny, Switzerland.

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/diagnosis ; Quality of Life*

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2415407. Date of Electronic Publication: 2024 Oct 17.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).

  • Authors : Gargiulo L; Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/pathology ; Severity of Illness Index*

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2411855. Date of Electronic Publication: 2024 Oct 10.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Monoclonal antibodies in phase II and III trials for moderate to severe atopic dermatitis.

  • Authors : Patel HA; Center for Dermatological Research, Wake Forest University, Winston-Salem, NC, USA.; Tran L

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/immunology ; Clinical Trials, Phase II as Topic*

  • Source: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2024 Dec; Vol. 29 (4), pp. 361-368. Date of Electronic Publication: 2024 Oct 27.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals.

  • Authors : Paolino G; Unit of Dermatology and Cosmetology, IRCCS Ospedale San Raffaele, Milan, Italy.; Narcisi A

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/pathology ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2351489. Date of Electronic Publication: 2024 May 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Psychiatric Comorbidities of Childhood-onset Atopic Dermatitis in Relation to Eczema Severity: A Register-based Study among 28,000 Subjects in Finland.

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/epidemiology ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/psychology ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/diagnosis

  • Source: Acta dermato-venereologica [Acta Derm Venereol] 2024 Nov 13; Vol. 104, pp. adv40790. Date of Electronic Publication: 2024 Nov 13.Publisher: MJS Publishing Country of Publication: Sweden NLM ID: 0370310 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-2057

Record details

×
Academic Journal

Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab.

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/diagnosis ; Severity of Illness Index*

  • Source: Archives of dermatological research [Arch Dermatol Res] 2024 Nov 06; Vol. 316 (10), pp. 747. Date of Electronic Publication: 2024 Nov 06.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X

Record details

×
Academic Journal

Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China.

  • Authors : Wang Y; Department of Dermatology, The First Affiliated Hospital of Chongqing College of Traditional Chinese Medicine, Chongqing, China.; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/immunology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 01; Vol. 15, pp. 1419164. Date of Electronic Publication: 2024 Nov 01 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study.

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/diagnosis ; Severity of Illness Index*

  • Source: International journal of dermatology [Int J Dermatol] 2024 Nov; Vol. 63 (11), pp. e289-e295. Date of Electronic Publication: 2024 Jun 21.Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis.

  • Authors : Silverberg JI; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.; Gooderham M

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/drug therapy ; Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/therapy ; Decision Making, Shared*

  • Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Nov; Vol. 38 (11), pp. 2139-2148. Date of Electronic Publication: 2024 Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  912 results for ""Dermatitis, Atopic""